US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 49.310
  • -1.280-2.53%
Close Feb 14 16:00 ET
  • 49.550
  • +0.240+0.49%
Post 20:01 ET
9.13BMarket Cap-42.51P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Exact Sciences Q4 2024 Estimates Date

Currency：USDFeb 19, 2025

Estimate YoY
Revenue
701.45M
+8.44%
EPS
-0.32
-16.93%
Analyst Rating
Strong Buy

Feb 16, 2025

Exact Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 697.887M--
Feb 19, 20252024/Q4-- / 701.450M--
Nov 5, 20242024/Q3708.655M / 716.988M--
Jul 31, 20242024/Q2699.264M / 690.103M--
May 8, 20242024/Q1637.524M / 626.805M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 697.887M--
Feb 19, 20252024/Q4-- / 701.450M--
Nov 5, 20242024/Q3708.655M / 716.988M--
Jul 31, 20242024/Q2699.264M / 690.103M--
May 8, 20242024/Q1637.524M / 626.805M--

Unlock Free Earnings Estimates

Exact Sciences Earnings Reports

  • Exact Sciences | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 17:12 ET

  • Exact Sciences | 10-Q: Q2 2024 Earnings Report

    Jul 31, 2024 17:11 ET

  • Exact Sciences | 10-Q: Q1 2024 Earnings Report

    May 8, 2024 17:07 ET

  • Exact Sciences | 10-K: FY2023 Annual Report

    Feb 21, 2024 17:12 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 16, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cancer Research
    Cancer Research
    Intraday-1.84%